Author:
Stacher Georg,Weber Ute,Stacher-janotta Giselheid,Bauer Peter,Huber Kurt,Holzäpfel Antje,Krause Günter,Steinborn Claus
Subject
Pharmacology (medical),Pharmacology
Reference47 articles.
1. An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy;Tabona;Eur J Cancer,1990
2. Clinical studies with granisetron, a new 5-HT3 receptor antagonist, for the treatment of cancer chemotherapy-induced emesis. The Granisetron Study Group;Joss;Eur J Cancer,1993
3. Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis;Perez;J Clin Oncol,1995
4. Ondansetron compared with granisetron in the prophylaxis of cyclophosphamide-induced emesis in out-patients: a multicentre, double-blind, double-dummy, randomised, parallel-group study. Emesis Study Group for Ondansetron and Granisetron in Breast Cancer Patients;Stewart;Oncology,1995
5. Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron);Goldberg;Digestion,1996
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献